Polyarteritis nodosa: Difference between revisions
Sargun Walia (talk | contribs) No edit summary |
|||
(5 intermediate revisions by 4 users not shown) | |||
Line 10: | Line 10: | ||
{{Polyarteritis nodosa}} | {{Polyarteritis nodosa}} | ||
{{CMG}}; {{AE}} {{CZ}}; [[User:Haritha|Haritha Machavarapu, M.B.B.S.]] | {{CMG}} {{APM}}; {{AE}}{{SSW}}{{OO}} {{CZ}}; [[User:Haritha|Haritha Machavarapu, M.B.B.S.]] | ||
{{SK}} PAN; [[Adolph Kussmaul|Kussmaul]] disease; Kussmaul-Meier disease; periarteritis nodosa | {{SK}} PAN; [[Adolph Kussmaul|Kussmaul]] disease; Kussmaul-Meier disease; periarteritis nodosa | ||
Line 24: | Line 24: | ||
==[[Polyarteritis nodosa causes|Causes]]== | ==[[Polyarteritis nodosa causes|Causes]]== | ||
==[[Differentiating | ==[[Differentiating Polyarteritis nodosa from other diseases|Differentiating Polyarteritis nodosa from other Diseases]]== | ||
==[[Polyarteritis nodosa epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Polyarteritis nodosa epidemiology and demographics|Epidemiology and Demographics]]== | ||
Line 39: | Line 39: | ||
==Treatment== | ==Treatment== | ||
[[Polyarteritis nodosa medical therapy|Medical Therapy]] | [[Polyarteritis nodosa primary prevention|Primary Prevention]] | [[Polyarteritis nodosa cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Polyarteritis nodosa future or investigational therapies|Future or Investigational Therapies]] | [[Polyarteritis nodosa medical therapy|Medical Therapy]] | [[Polyarteritis nodosa surgery|Surgery]] | [[Polyarteritis nodosa primary prevention|Primary Prevention]] | [[Polyarteritis nodosa secondary prevention|Secondary Prevention]] |[[Polyarteritis nodosa cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | |[[Polyarteritis nodosa future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Polyarteritis nodosa case study one|Case #1]] | [[Polyarteritis nodosa case study one|Case #1]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category: | [[Category:Nephrology]] | ||
Latest revision as of 04:24, 22 May 2018
For patient information, click here
For the heart in Polyarteritis Nodosa click here
Template:DiseaseDisorder infobox
Polyarteritis nodosa Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Polyarteritis nodosa On the Web |
American Roentgen Ray Society Images of Polyarteritis nodosa |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[3]Olufunmilola Olubukola M.D.[4] Cafer Zorkun, M.D., Ph.D. [5]; Haritha Machavarapu, M.B.B.S.
Synonyms and keywords: PAN; Kussmaul disease; Kussmaul-Meier disease; periarteritis nodosa
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Polyarteritis nodosa from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiography | Chest X Ray | CT | MRI | Other Diagnostic Studies | Other Imaging Findings
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention |Cost-Effectiveness of Therapy | |Future or Investigational Therapies
Case Studies